Continuing Medical Education Program - The Medical Letter

The purpose of The Medical Letter Continuing Medical Education Program is to provide a means for health care professionals (primarily physicians and pharmacists) to keep up to date with new drugs that are approved by the FDA, as well as keep up with the standard of care treatments for specific indications. Specifically, the content of The Medical Letter Continuing Medical Education Program covers the mechanisms of action, pharmacokinetics, clinical trials, adverse effects, interactions, dosages and routes of administration of the drugs discussed. Participants are required to answer exam questions based on the content of The Medical Letter. Importantly, the objectives of developing the content on which the exam is based are to educate the participant, impact clinical practice and improve patient outcomes. The Medical Letter's unbiased content is free of commercial influence and financial sponsorship. The Medical Letter does not accept advertising, grants or donations. The program is completely funded by fees paid by the exam participants. The Medical Letter Continuing Medical Education program is accredited by: ACCME AAFP ACPE.

You may earn up to 26 credits per year, by choosing one of the following:

	FREE Individual Exams – Freely available only to active subscribers of The Medical Letter. Answer six questions per issue and submit answers online. Earn one credit/exam. 1 credit/exam Subscribe now

	Comprehensive Exam – Available online or in print to Medical Letter subscribers, this 78 question test enables you to earn 13 AMA PRA Category 1 credits immediately with the successful completion of the test. Take the exam online and receive your Continuing Medical Education certificate within 3 business days! Our Comprehensive exams allow you to test at your own pace in the comfort of your home or office. Save airfare, conference expenses and time away from your practice. Comprehensive tests are offered every January and July enabling you to earn up to 26 credits per year. Order using the form below. $44.50/13 credits Subscribe now

	Purchase Individual Exams – Available to non-subscribers. Access content and answer six questions, online only, for any available issue and earn one credit. Order using the form below. 1 credit/exam; $12.00/credit

The Medical Letter Individual Exams — Online Only

I would like to order the following Online Per Issue Individual Exams eligible for 1 credit each:

$12
per exam

	1391 Drugs for Menopausal Symptoms; Choice of Drugs for Heparin-Induced Thrombocytopenia Expires 05/28/2013
	1392 Peginesatide (Omontys) for Anemia in Chronic Kidney Disease; Mifepristone (Korlym) for Cushing's Syndrome; Axitinib (Inlyta) for Advanced Renal Cell Carcinoma Expires 06/11/2013
	1393 Bisphosphonates - Duration of Use Revisited; Intraosseous Infusion for Rapid Vascular Access; A New Scorpion Antivenom
	1394 Vismodegib (Erivedge) for Basal Cell Carcinoma; An Imaging Agent for Amyloid; Renal Sympathetic Denervation for Hypertension
	1395 Drugs for Urinary Tract Infections; What Comes After Metformin for Type 2 Diabetes; Pertuzumab (Perjeta) for HER2-Positive Metastatic Breast Cancer
	1396 PSA Reconsidered; Ivermectin (Sklice) Topical Lotion for Head Lice; Tablet Splitting; Truvada for HIV Prevention
	1397 Ezogabine (Potiga) for Epilepsy; Prosthetic Heart Valves
	1398 Two New Drugs for Weight Loss; Citalopram (Celexa) and QT Interval
	1399 Prevention and Treatment of Pertussis; Endocarditis Prophylaxis for Dental Procedures; Insect Repellents
	1400 Influenza Vaccine for 2012-2013; Choice of an Oral Anticoagulant in Atrial Fibrillation
	1401 Drugs for Hepatitis C; Fish Oil Supplements; Effervescent Alendronate
	1402 Azelastine/Fluticasone Propionate (Dymista) for Seasonal Allergic Rhinitis; Pneumococcal Vaccine for Adults
	1403 New Drugs for Multiple Sclerosis; Linaclotide (Linzess) for Constipation
	1404 Electronic Cigarettes for Smoking Cessation; Delayed-Release Prednisone (Rayos); A 4-Drug Combination (Stribild) for HIV
	1405 Antiviral Drugs for Influenza 2012-2013; Aclidinium Bromide (Tudorza Pressair) for COPD
	1406 Cephalosporins for Patients with Penicillin Allergy; Choice of Drug-Eluting Stents; Carfilzomib (Kyprolis) for Multiple Myeloma
	1407 Tofacitinib (Xeljanz) for Rheumatoid Arthritis; Probiotics Revisited
	1408 FDA Requires Lower Dosing of Zolpidem; Colonoscopy Preparations; Absorica for Acne
	1409 Apixaban (Eliquis) - An New Oral Anticoagulant for Atrial Fibrillation; Quillivant XR - An Extended-Release Oral Suspension of Methylphenidate; Two New Seasonal Influenza Vaccines
	1410 Mirabegron (Myrbetriq) for Overactive Bladder; Laser Treatment of Onychomycosis; PPIs and Fracture Risk
	1411 Drugs for Hypertriglyceridemia; Misoprostol for Miscarriage
	1412 A New Low-Dose Levonorgestrel-Releasing IUD (Skyla); Budesonide (Uceris) for Ulcerative Colitis; Mitomycin Solution (Mitosol) for Glaucoma Surgery
	1413 Two New Drugs for Homozygous Familial Hypercholesterolemia; Raxibacumab for Anthrax; FDA Azithromycin Warning
	1414 Teduglutide Injection (Gattex) for Short Bowel Syndrome; Botox for Overactive Bladder
	1415 Icosapent Ethyl (Vascepa) for Severe Hypertriglyceridemia; Long-Acting Injectable Aripiprazole (Ablify Maintena) for Schizophrenia
	1416 Canagliflozin (Invokana) for Type 2 Diabetes; Pasireotide (Signifor) for Cushing's Disease
	1417 Alogliptin (Nesina) for Type 2 Diabetes; Omalizumab (Xolair) for Chronic Urticaria Available 05/24/2013

ACCME The Medical Letter is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical Letter Inc. designates this enduring material for a maximum of 26 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Continuing Medical Education (CME) activity was planned and produced in accordance with the ACCME Essentials and Policies.

AAFP This Enduring Material activity, The Medical Letter Continuing Medical Education Program, has been reviewed and is acceptable for up to 26 Prescribed credit(s) by the American Academy of Family Physicians. AAFP certification begins January 1, 2013. Term of approval is for one year from this date with the option of yearly renewal. Credit may be claimed for 1 year from the date of each issue. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Council on Pharmacy Education

The Medical Letter is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.